Life Sciences Businesses Debate
Full Debate: Read Full DebateDepartment: Department for Business and Trade
Baroness Jones of Whitchurch
Main Page: Baroness Jones of Whitchurch (Labour - Life peer)Department Debates - View all Baroness Jones of Whitchurch's debates with the Department for Business and Trade
Life Sciences Businesses
Baroness Jones of Whitchurch Excerpts(2 months, 2 weeks ago)
Lords ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Baroness Jones of Whitchurch
To ask His Majesty’s Government what further steps they intend to take to support life sciences businesses starting up and scaling up in the United Kingdom.
The Minister of State, Department for Business and Trade (Lord Johnson of Lainston) (Con)
The life sciences sector is among the UK’s most globally competitive, with a turnover of more than £108 billion in 2022 and employing over 300,000 people. Supporting the sector is a priority for this Government, as demonstrated through a range of initiatives. These include a £520 million fund supporting life science manufacturing, reforms to the UK’s pension market to boost funding for companies, grants for early-stage companies via Innovate UK, export support and initiatives to accelerate the NHS adopting innovation.
Baroness Jones of Whitchurch (Lab)
I thank the Minister for that reply. We all understand the importance of the life sciences sector to our economy and to the health of our nation. Can he explain why, under this Government, the UK’s share of global exports in this sector was down from 9% to 4%, and our share of global R&D fell from 7.2% to 3.2%, between 2012 and 2020? Does that not represent a complete failure by this Government to create the stability and certainty in which life science innovators can flourish?
Lord Johnson of Lainston (Con)
I am always grateful for challenge from any Peer in this House, but I have very different figures. If I look at the turnover of the life sciences sector, I find that, in 2022 alone, it was up by 13%, and it is up by 40% since 2015. There is a whole lot more that we can do, but I am proud of our record when it comes to garnering investment—FDI, which is particularly my function—into the UK life sciences sector. Over a three-year average, we are third in the world, behind only the United States and Germany. That is rather a significant tribute to the people in this sector and the Government’s support of it.